3.Recent progress of dry powder inhalation of proteins and peptides.
Jie-yu ZHOU ; Lan ZHANG ; Shi-rui MAO
Acta Pharmaceutica Sinica 2015;50(7):814-823
To provide theoretical and practical basis for the successful formulation design of physically-mixed inhalation dry powder of proteins and peptides, related references were collected, analyzed and summarized. In this review drug micronization technology and commonly used carriers for inhalation dry powder preparation were introduced. For proteins and peptides, supercritical fluid technology and spray-drying are more suitable because of their capabilities of keeping drug activity. Being approved by U. S. Food and Drug Administration, lactose has been extensively used as carriers in many inhalation products. Formulation and process factors influencing drug deposition in the lung, including carrier properties, drug-carrier ratio, blending order, mixing methods, mixing time and the interaction between drug and carrier, were elucidated. The size, shape and surface properties of carries all influence the interaction between drug and carrier. Besides, influence of micromeritic properties of the dry powder, such as particle size, shape, density, flowability, charge, dispersibility and hygroscopicity, on drug deposition in the lung was elaborated. Among these particle size plays the most crucial role in particle deposition in the lung. Moreover, based on the mechanisms of powder dispersity, some strategies to improve drug lung deposition were put forward, such as adding carrier fines, adding adhesive-controlling materials and reprocessing micronized drug. In order to design physically-mixed inhalation dry powder for proteins and peptides with high lung deposition, it is essential to study drug-carriers interactions systematically and illustrate the potential influence of formulation, process parameters and micromeritic properties of the powder.
Administration, Inhalation
;
Drug Carriers
;
chemistry
;
Dry Powder Inhalers
;
Lactose
;
chemistry
;
Particle Size
;
Peptides
;
administration & dosage
;
Powders
;
administration & dosage
;
Surface Properties
;
Technology, Pharmaceutical
4.Methodology of DNA staining by Azure A.
Jian-yun ZHOU ; Song HE ; Lan YU ; Yan GUO
Chinese Journal of Pathology 2006;35(9):568-569
Azure Stains
;
chemistry
;
DNA, Neoplasm
;
analysis
;
chemistry
;
Humans
;
Rosaniline Dyes
;
chemistry
;
Staining and Labeling
;
economics
;
methods
;
Stomach Neoplasms
;
genetics
;
pathology
5.Vasculogenic mimicry in laryngeal squamous cell carcinoma and its clinicopathological significance.
Shiwu WU ; Lan YU ; Lei ZHOU ; Zenong CHENG ; Danna WANG
Journal of Biomedical Engineering 2014;31(4):865-869
The present paper aims to investigate whether or not vasculogenic mimicry (VM) exists in laryngeal squamous cell carcinoma (LSCC), and to elucidate its relationship to microvessel density (MVD), galectin-3 (Gal-3) expression, and clinicopathological factors of patients with LSCC. VM, score of MVD and expression of Gal-3 protein were detected by immunohistochemistry and histochemistry in 83 specimens of LSCC tissue and 20 specimens of normal laryngeal tissue. The positive rate of VM in normal laryngeal tissues was 0%, and was 33.7% in LSCC tissues. There was a significant difference between the two groups (P<0. 01). VM or MVD was significantly related to differentiation, pTNM stages and lymph node metastasis of LSCC (P<0.05), but not to age, gender and tumor site (P>0. 05). And there was a positive correlation between every two of VM, score of MVD, and Gal-3 protein (P< 0. 05). The results suggest that expression of Gal-3 protein may be related to the initiation, angiogenesis and VM formation in LSCC; And VM, angiogenesis and Gal-3 protein may be involved in the development, invasion and metastasis of LSCC.
Carcinoma, Squamous Cell
;
blood supply
;
Galectin 3
;
metabolism
;
Head and Neck Neoplasms
;
blood supply
;
Humans
;
Immunohistochemistry
;
Laryngeal Neoplasms
;
blood supply
;
Lymphatic Metastasis
;
Neovascularization, Pathologic
;
Prognosis
7.Correlation between expression of ALDH1/ABCG2 and microvessel for-mation in epithelial ovarian cancer
Lan YU ; Wenqing SONG ; Lei ZHOU ; Shiwu WU ; Danna WANG
Chinese Journal of Pathophysiology 2016;32(10):1807-1814
AIM:To elucidate the correlation between the expression of aldehyde dehydrogenase 1 (ALDH1)/ATP-binding cassette subfaminly G member 2 ( ABCG2 ) and microvessel density ( MVD ) in epithelial ovarian cancer ( EOC) .METHODS:In 198 specimens of EOC and 60 specimens of ovarian benign epithelial tumor tissues , the protein expression of ALDH1/ABCG2 and CD105 ( microvessel marker ) was detected by immunohistochemical staining .RE-SULTS:The positive rates of ALDH1 and ABCG2 in the EOC were 64.1%and 61.6%, respectively , while the positive rates in benign epithelial tumor tissues were 8.3%and 6.7%, respectively , and there were significant differences between them (P<0.05).In EOC and benign epithelial tumor tissues , the MVD were 22.6 ±9.7 and 5.03 ±3.35, respectively, and the difference was also significant (P<0.05).The expression of ALDH1 and ABCG2 in EOC was significantly related to differentiation, FIGO stage,and abdominal organ and lymph node metastasis (P<0.05).MVD had correlation with dif-ferentiation, FIGO stage, ascite, and abdominal organ and lymph node metastasis (P<0.05).MVD had positive correla-tion with the expression of ALDH1 and ABCG2 (P<0.01).There was also a positive correlation between the expression of ALDH1 and ABCG2 ( P<0.01) .Over-expression of ALDH1/ABCG2 and MVD≥23 were related to the poor prognosis . The survival rates in ALDH1/ABCG2 positive and MVD≥23 groups were significantly lower than those in ALDH 1/ABCG2 negative and MVD<23 groups (P<0.05).The FIGO stage, the expression of ALDH1/ABCG2 and MVD were indepen-dent prognosis factors of EOC ( P<0.05 ) .CONCLUSION: The results suggest that the expression of ALDH 1/ABCG2 and MVD in EOC are related to differentiation , lymph node metastasis , clinical stage and prognosis .Combined detection of these indexes may play an important role in predicting the progression and prognosis of EOC .
8.Influence of the excision of cardiac sympathetic nerves on QT dispersion
Huiyun ZHOU ; Shengxi ZHEN ; Xi LAN ; Yu LIU ; Ping SHU
Chinese Journal of Pathophysiology 2000;0(07):-
AIM: To observe and study the influence of cardiac sympathetic nerve on QT dispersion (QTd) and the circadian variations of QTd in experimental rabbits. METHODS: The rabbits were divided into experimental group (without cardiac sympathetic control by operation) and control group (with retained cardiac sympathetic control by operation, sham operation). QTd of both groups were measured and compared before and after the operation. The circadian variations of QTd were also observed in both groups. RESULTS: QTd in experimental group decreased significantly after the cardiac sympathetic nerves were excised (P
9.Effect of polypeptide from Chlamys farreri on PI3K/Akt and ASK1-JNK signal transduction pathway in murine thymocytes after UVB radiation
Haiying CHEN ; Yingbin ZHOU ; Chunbo WANG ; Wengong YU ; Xiaoming LAN
Chinese Journal of Marine Drugs 1994;0(01):-
Objective To study the effects of polypeptide from Chlamys farreri(PCF) on PI3K/Akt and ASK1-JNK signal transduction pathway in thymocytes after ultraviolet B radiation.Methods Murine thymocytes were exposed to UVB radiation.The reactive oxygen species(ROS) level in thymocytes was detected by colormatching.The activation of Akt was investigated by western-blot.ASK1,JNK activation,mitochondria memberine potential and DNA ladder were also investigated after pretreatment with or without PI3K/Akt pathway inhibitor LY294002.Results PCF could activate Akt,inhibit the activation of the ASK1 apoptosis pathway in murine thymocyte radiated by UVB.Conclusion PCF decreased ROS level,increased Akt activity and inducing ASK1 degradation leading to the inhibition of ASK1-JNK induced apoptosis.
10.Clinical efficacy of ulinastatin combined with penehyclidine hydrochloride in prevention and treatment of highly irritant gas poisoning.
Yu-fa LIU ; Li-jun SU ; Cui-lan ZHOU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2013;31(6):461-462
Adult
;
Female
;
Gas Poisoning
;
drug therapy
;
Glycoproteins
;
therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Quinuclidines
;
therapeutic use
;
Treatment Outcome
;
Young Adult